Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Discovery And Development

Treatment reduces dangerous side effects of cancer treatment in children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according...

Researchers identify potential target for brain tumour drug

Researchers believe that a drug that targets the body's immune cells could provide a new treatment for malignant brain tumours.

CRT and ValiRx sign licensing deal to develop prostate cancer treatment

CANCER RESEARCH TECHNOLOGY has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant...

Daisies lead to new leukaemia drug

Scientists could be on their way to creating a new leukaemia therapy extracted from a daisy-like plant, a new report has indicated.

CRT and Bayer Schering Pharma to investigate new therapeutic approach in gynaecological and oncological diseases

CANCER RESEARCH TECHNOLOGY has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments...

'Impressive' new lung cancer drug revealed

Scientists have identified a new drug which could be used to treat people with small cell lung cancer.

Cancer Research UK launches medicine manufacturing hub for life-saving research

Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today with the manufacture of its first product - an antibody...

Sea sponge drug may extend advanced breast cancer survival

A new drug, based on a natural extract from sea sponge, may help to extend the lives of women with advanced breast cancer, UK scientists have found.

CRT, Newcastle University and KuDOS advance DNA-PK research with a new licence

Cancer Research Technology Limited (CRT) has licensed the rights to its DNA-dependent protein kinase (DNA-PK)* inhibitor programme to collaboration partner KuDOS...

Ras protein discovery could lead to drug

US researchers have taken the first steps towards designing a drug to target one of the most important proteins in cancer.

Pages